Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

FDA approves once-daily Viramune XR for use in combination for HIV-1 infection

April 6, 2011

Phase III elvitegravir trial in HIV meets primary objective

March 24, 2011

TaiMed Biologics and Ambrilia sign worldwide agreement for HIV programs

March 18, 2011

Novel HIV integrase inhibitors patented by Merck & Co.

March 16, 2011

German researchers present novel agents for HIV

March 14, 2011

Phase I/II trials assess safety and immunogenicity of HIV vaccine F4/AS01

March 14, 2011

PharmaMar reports novel inhibitors of HIV reverse transcriptase

March 11, 2011

First-in-human data on TUTI-16 support its use in asymptomatic HIV-1-infected subjects

March 11, 2011

HIV vaccine MVA-B is safe and appears immunogenic in healthy subjects

March 10, 2011

Kaletra label changed due to health risks in premature babies

March 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026